TREATMENT OF EWING SARCOMA WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
- 1 January 1981
- journal article
- research article
- Vol. 65 (3-4) , 241-244
Abstract
Three patients with disseminated, relapsed Ewing''s sarcoma refractory to conventional chemotherapy were treated with high-dose melphalan, cyclophosphamide pretreatment and bone marrow autotransplantation. Two patients achieved complete remission and 1 achieved partial remission. The 2 patients who achieved complete remission remain disease-free at 12 and 13 mo. High-dose melphalan is effective when conventional approaches have failed.This publication has 4 references indexed in Scilit:
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- ACCELERATION OF BONE-MARROW RECOVERY BY PRE-TREATMENT WITH CYCLOPHOSPHAMIDE IN PATIENTS RECEIVING HIGH-DOSE MELPHALANThe Lancet, 1978
- Curability of ewing's sarcoma and considerations for future therapeutic trialsCancer, 1978
- CYCLOPHOSPHAMIDE THERAPY IN CHILDREN WITH EWING SARCOMA1962